Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 14/20 | 0.55 |
| ▸ | MEN1 | O00255 | 12/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.55 |
| ▸ | MAPT | P10636 | 9/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.55 |
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 7/20 | 0.44 |
| ▸ | EGFR | P00533 | 7/20 | 0.44 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.44 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.44 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13428212 | 0.81 | SLC16A3 (0.47) | KMT2AALDH1A1EGFRKDM4EHPGD | |
| SCHEMBL14540647 | 0.81 | SLC16A3 (0.47) | KMT2AALDH1A1EGFRKDM4EHPGD | |
| SCHEMBL597887 | 0.81 | SLC16A3 (0.47) | KMT2AALDH1A1EGFRKDM4EHPGD | |
| SCHEMBL1227300 | 0.81 | KMT2A (0.56) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL16301917 | 0.80 | MAPT (0.51) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL24043357 | 0.78 | KMT2A (0.46) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL23373774 | 0.77 | ALDH1A1 (0.49) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL24605624 | 0.77 | NQO2 (0.43) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL10253234 | 0.77 | ALDH1A1 (0.44) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL13989159 | 0.75 | KMT2A (0.53) | KMT2AMEN1ALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4427033-B1 | METHOD FOR QUALITATIVE AND QUANTITATIVE DETERMINATION OF PROTEIN AGGREGATES | PAIA BIOTECH GMBH (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4662484-A1 | MULTISENSOR ARRAYS, MULTISENSOR SYSTEMS AND RELATED METHODS | Linxens Holding (FR) | 2025-12-17 | — | — | EP | claimed |
| CN-112639470-B | Diagnostic method for amyloid-related disease | 阿米罗伊迪亚瑞典股份公司 | 2025-02-25 | — | — | CN | claimed |
| EP-4427033-A1 | METHOD FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF PROTEIN AGGREGATES | PAIA Biotech GmbH (DE) | 2024-09-11 | — | — | EP | claimed |
| US-12076406-B2 | Conjugates for targeting and clearing aggregates | MEDIMMUNE LIMITED (GB) | 2024-09-03 | — | — | US | claimed |
| WO-2024165881-A1 | MULTISENSOR ARRAYS, MULTISENSOR SYSTEMS AND RELATED METHODS | LINXENS HOLDING (FR) | 2024-08-15 | — | — | WO | claimed |
| EP-3913010-B1 | SIMPLIFIED METHOD FOR POLYURETHANE SYNTHESIS CONTROL BASED ON THE USE OF FLUORESCENT PROBES | UNIV PISA (IT) | 2024-06-19 | — | — | EP | claimed |
| EP-3775884-B1 | METHOD FOR THE DIAGNOSIS OF AMYLOID-ASSOCIATED DISEASES | AMYLOIDIA SWEDEN AB (SE) | 2024-05-08 | — | — | EP | claimed |
| CN-117969472-A | Method for high-throughput determination of heat stability and iron saturation of lactoferrin | 陕西科技大学 | 2024-05-03 | — | — | CN | claimed |
| CN-116413167-A | Blood analyzer | 深圳市瑞图生物技术有限公司 | 2023-07-11 | — | — | CN | claimed |
| WO-2023079052-A1 | METHOD FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF PROTEIN AGGREGATES | PAIA BIOTECH GMBH (DE) | 2023-05-11 | — | — | WO | claimed |
| CN-115855902-A | Method and material for detecting concentration of tricresyl phosphate in water body | 西南交通大学 | 2023-03-28 | — | — | CN | claimed |
| CN-115494038-A | In-situ quick detection method for stability of nano-emulsion-based dispersion system and application | 江南大学 | 2022-12-20 | — | — | CN | claimed |
| EP-2802871-B1 | CHARACTERIZATION OF SUBVISIBLE PARTICLES USING A PARTICLE ANALYZER | TAKEDA PHARMACEUTICALS CO (JP) | 2022-07-27 | — | — | EP | claimed |
| US-20220026446-A1 | METHOD FOR THE DIAGNOSIS OF AMYLOID-ASSOCIATED DISEASES | AMYLOIDIA SWEDEN AB (SE) | 2022-01-27 | — | — | US | claimed |
| WO-2016001644-A1 | DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2016-01-07 | — | — | WO | claimed |
| EP-2802871-A2 | CHARACTERIZATION OF SUBVISIBLE PARTICLES USING A PARTICLE ANALYZER | Baxter International Inc (US) | 2014-11-19 | — | — | EP | claimed |
| WO-2013106772-A2 | CHARACTERIZATION OF SUBVISIBLE PARTICLES USING A PARTICLE ANALYZER | BAXTER INTERNATIONAL, INC. (US) | 2013-07-18 | — | — | WO | claimed |
| EP-4427033-B1 | METHOD FOR QUALITATIVE AND QUANTITATIVE DETERMINATION OF PROTEIN AGGREGATES | PAIA BIOTECH GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2005073697-A1 | LOCAL FLOW AND SHEAR STRESS SENSOR BASED ON MOLECULAR ROTORS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2005-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076406-B2 | Conjugates for targeting and clearing aggregates | FCGR2A, FCGR3B, FCGR1A | KMT2A 2666/4885MEN1 2195/4885ALDH1A1 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.